These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 28886145)

  • 1. Application of a whole blood mycobacterial growth inhibition assay to study immunity against Mycobacterium tuberculosis in a high tuberculosis burden population.
    Baguma R; Penn-Nicholson A; Smit E; Erasmus M; Day J; Makhethe L; de Kock M; Hughes EJ; van Rooyen M; Pienaar B; Stone L; Hanekom W; Brennan MJ; Wallis RS; Hatherill M; Scriba TJ
    PLoS One; 2017; 12(9):e0184563. PubMed ID: 28886145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection against mycobacterial infection: A case-control study of mycobacterial immune responses in pairs of Gambian children with discordant infection status despite matched TB exposure.
    Basu Roy R; Sambou B; Sissoko M; Holder B; Gomez MP; Egere U; Sillah AK; Koukounari A; Kampmann B
    EBioMedicine; 2020 Sep; 59():102891. PubMed ID: 32675024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mycobacterial Lipoprotein Z Triggers Efficient Innate and Adaptive Immunity for Protection Against
    Chen Y; Xiao JN; Li Y; Xiao YJ; Xiong YQ; Liu Y; Wang SJ; Ji P; Zhao GP; Shen H; Lu SH; Fan XY; Wang Y
    Front Immunol; 2018; 9():3190. PubMed ID: 30700988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Lee H; Kim J; Kang YA; Kim DR; Sim B; Zelmer A; Fletcher HA; Dockrell HM; Smith SG; Cho SN
    Front Immunol; 2019; 10():896. PubMed ID: 31105706
    [No Abstract]   [Full Text] [Related]  

  • 6. Specific Host Signatures for the Detection of Tuberculosis Infection in Children in a Low TB Incidence Country.
    Dreesman A; Corbière V; Libin M; Racapé J; Collart P; Singh M; Locht C; Mascart F; Dirix V
    Front Immunol; 2021; 12():575519. PubMed ID: 33790886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in IgG responses against infection phase related Mycobacterium tuberculosis (Mtb) specific antigens in individuals exposed or not to Mtb correlate with control of TB infection and progression.
    Coppola M; Arroyo L; van Meijgaarden KE; Franken KL; Geluk A; Barrera LF; Ottenhoff THM
    Tuberculosis (Edinb); 2017 Sep; 106():25-32. PubMed ID: 28802401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effects of Oral Liposomal Glutathione and In Vitro Everolimus in Altering the Immune Responses against
    To K; Cao R; Yegiazaryan A; Owens J; Sasaninia K; Vaughn C; Singh M; Truong E; Sathananthan A; Venketaraman V
    Biomol Concepts; 2021 May; 12(1):16-26. PubMed ID: 33966361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of age and sex on mycobacterial immunity in an area of high tuberculosis incidence.
    Gallant CJ; Cobat A; Simkin L; Black GF; Stanley K; Hughes J; Doherty TM; Hanekom WA; Eley B; Beyers N; Jaïs JP; van Helden P; Abel L; Alcaïs A; Hoal EG; Schurr E
    Int J Tuberc Lung Dis; 2010 Aug; 14(8):952-9. PubMed ID: 20626938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gamma interferon responses induced by a panel of recombinant and purified mycobacterial antigens in healthy, non-mycobacterium bovis BCG-vaccinated Malawian young adults.
    Black GF; Weir RE; Chaguluka SD; Warndorff D; Crampin AC; Mwaungulu L; Sichali L; Floyd S; Bliss L; Jarman E; Donovan L; Andersen P; Britton W; Hewinson G; Huygen K; Paulsen J; Singh M; Prestidge R; Fine PE; Dockrell HM
    Clin Diagn Lab Immunol; 2003 Jul; 10(4):602-11. PubMed ID: 12853392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of individual-level factors on Ex vivo mycobacterial growth inhibition: Associations of immune cell phenotype, cytomegalovirus-specific response and sex with immunity following BCG vaccination in humans.
    Prabowo SA; Smith SG; Seifert K; Fletcher HA
    Tuberculosis (Edinb); 2019 Dec; 119():101876. PubMed ID: 31698310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evolution of IGRA researches].
    Ariga H; Harada N
    Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of humoral immunoglobulins M and G directed against mycobacterial antigen 60 failed to diagnose primary tuberculosis and mycobacterial adenitis in children.
    Turneer M; Van Nerom E; Nyabenda J; Waelbroeck A; Duvivier A; Toppet M
    Am J Respir Crit Care Med; 1994 Dec; 150(6 Pt 1):1508-12. PubMed ID: 7952608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tools for Assessing the Protective Efficacy of TB Vaccines in Humans:
    Tanner R; Satti I; Harris SA; O'Shea MK; Cizmeci D; O'Connor D; Chomka A; Matsumiya M; Wittenberg R; Minassian AM; Meyer J; Fletcher HA; McShane H
    Front Immunol; 2019; 10():2983. PubMed ID: 31998295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early cellular immune response to a new candidate mycobacterial vaccine antigen in childhood tuberculosis.
    Schepers K; Dirix V; Mouchet F; Verscheure V; Lecher S; Locht C; Mascart F
    Vaccine; 2015 Feb; 33(8):1077-83. PubMed ID: 25583385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimisation of a murine splenocyte mycobacterial growth inhibition assay using virulent Mycobacterium tuberculosis.
    Jensen C; Lindebo Holm L; Svensson E; Aagaard C; Ruhwald M
    Sci Rep; 2017 Jun; 7(1):2830. PubMed ID: 28588268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new tool for tuberculosis vaccine screening: Ex vivo Mycobacterial Growth Inhibition Assay indicates BCG-mediated protection in a murine model of tuberculosis.
    Zelmer A; Tanner R; Stylianou E; Damelang T; Morris S; Izzo A; Williams A; Sharpe S; Pepponi I; Walker B; Hokey DA; McShane H; Brennan M; Fletcher H
    BMC Infect Dis; 2016 Aug; 16():412. PubMed ID: 27519524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro cellular and cytokine responses to mycobacterial antigens: application to diagnosis of tuberculosis infection and assessment of response to mycobacterial vaccines.
    Lein AD; Von Reyn CF
    Am J Med Sci; 1997 Jun; 313(6):364-71. PubMed ID: 9186152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of the relationships between immune-mediated inhibition of mycobacterial growth and other potential surrogate markers of protective Mycobacterium tuberculosis immunity.
    Hoft DF; Worku S; Kampmann B; Whalen CC; Ellner JJ; Hirsch CS; Brown RB; Larkin R; Li Q; Yun H; Silver RF
    J Infect Dis; 2002 Nov; 186(10):1448-57. PubMed ID: 12404160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of immune responses to Mycobacterium tuberculosis DosR regulon proteins following Mycobacterium bovis BCG vaccination.
    Lin MY; Geluk A; Smith SG; Stewart AL; Friggen AH; Franken KL; Verduyn MJ; van Meijgaarden KE; Voskuil MI; Dockrell HM; Huygen K; Ottenhoff TH; Klein MR
    Infect Immun; 2007 Jul; 75(7):3523-30. PubMed ID: 17502400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.